School of Medicine

Researchers at the School of Medicine have found a creative way to make a vaccine for norovirus, the leading cause of foodborne infections, by piggybacking on rotavirus, an unrelated virus for which there are already several highly effective vaccines.

Neuropathologist Sonika Dahiya, MD, a professor of pathology and immunology and chief of the neuro-oncology section at the School of Medicine, has been named to the Working Committee of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.

School of Medicine researchers have identified specific proteins that may help predict which COVID-19 patients may need to be placed on ventilators to breathe and which are most likely to die of the virus.

Lilianna Solnica-Krezel, the Alan A. and Edith L. Wolff Distinguished Professor and head of the Department of Developmental Biology at the School of Medicine, is to receive the 2023 Edwin G. Conklin Medal from the Society for Developmental Biology.

Vaccinating people with updated boosters as new variants of the virus that causes COVID-19 emerge could shore up population immunity even as the virus mutates, according to School of Medicine research. Such action could prevent another deadly COVID-19 wave.

Two researchers at Washington University in St. Louis took a closer look at the signals that coordinate a heartbeat at the molecular level. What they found may provide new insights into different heart conditions and how to develop better therapies.

New research from the School of Medicine suggests that transposable elements in various cancers potentially may be used to harness novel immunotherapies against tumors that don’t typically respond to immune-based treatments.

Three School of Medicine researchers — Enmanuel Perez, Ibrahim Saliu and Steffen Storck — have received funding from the Alzheimer’s Association for projects that aim to study and make progress against the disease.

School of Medicine scientists are working to minimize the risk of another devastating coronavirus pandemic by designing a vaccine that reduces sickness and death caused by all potentially deadly coronaviruses, including ones that have not yet affected people. The research is supported by an $8 million grant from the National Institutes of Health (NIH).

Daniel C. Link, MD, a highly regarded physician-scientist who treats patients with leukemia and also conducts innovative research, has been named director of the Division of Oncology in the Department of Medicine at the School of Medicine.